GLP-1 Coverage & Costs in Michigan (2026)
$79/month (Embody, compounded semaglutide, monthly plan) is the lowest monthly-plan price we have recorded among the programs on this page. Embody lists 48 states and our records do not name them, so confirm Michigan at intake.
The lowest recorded compounded tirzepatide price is $129/month (Embody, monthly plan). Among programs recorded as available in all 50 states, the lowest is $139/month (AgelessRx, compounded semaglutide, monthly plan). 6 of the 49 programs listed have no recorded price. Recorded prices cover medication and known program fees, not a verified total.
Michigan Medicaid Coverage for GLP-1
Medicaid: covered as of January 2026 (KFF)
KFF's map lists Michigan among the 13 state programs covering GLP-1s for obesity under fee-for-service as of January 2026. The RX Index, an independent tracker, later described Michigan's prior authorization as highly restrictive. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan.
- Source: KFF, Medicaid Coverage of and Spending on GLP-1s, Figure 1 (January 16, 2026). Read 2026-11-06.
- Source: The RX Index, state tracker, updated September 28, 2026. Read 2026-11-06.
Michigan Medicaid GLP-1 Prescriptions in 2025
607,982
#4
$672.1 million
Wegovy
Michigan Medicaid paid for 607,982 GLP-1 prescriptions in 2025, 5.4% of the 11.26 million paid nationally and number 4 of 51 (50 states and DC). It reimbursed pharmacies $672.1 million before manufacturer rebates, about $1,105 per prescription, and the most-filled product was Wegovy. These counts include diabetes prescriptions, not only weight loss. Wegovy, Zepbound and Saxenda, the brands approved for chronic weight management, made up 359,212 of those prescriptions (59.1%). Wegovy and Zepbound also carry other approved uses, so this is an upper bound on weight-loss use, not a count of it.
From 2021 to 2025, Michigan Medicaid GLP-1 prescriptions went from 97,503 to 607,982, 6.2 times the 2021 count. From 2024 to 2025 the count rose by 210,287.
97,503
195,940
354,264
397,695
607,982
| Product | MI Medicaid prescriptions, 2025 | Share |
|---|---|---|
| Wegovy | 194,841 | 32% |
| Zepbound | 161,929 | 26.6% |
| Trulicity | 90,652 | 14.9% |
| Ozempic | 87,007 | 14.3% |
| Mounjaro | 66,532 | 10.9% |
| Saxenda | 2,442 | 0.4% |
| Rybelsus | 2,292 | 0.4% |
| Liraglutide (generic) | 1,147 | 0.2% |
| Victoza | 1,073 | 0.2% |
| Byetta | 42 | under 0.1% |
| Bydureon | 25 | under 0.1% |
Source: CMS State Drug Utilization Data, 2025 (updated July 13, 2026), fee-for-service and managed care, all four quarters, compiled in our network's PriceTracker GLP-1 state table (read October 4, 2026); 2021 to 2024 summed by us from CMS's own yearly datasets with the same method, read November 9, 2026. CMS hides rows under 11 prescriptions, so small counts are slightly low. CMS publishes no per-enrollee rate here, so a total reflects the size of the program as much as use.
Michigan Employee Plan and Insurer GLP-1 Rules
Michigan State Health Plan (SHP PPO and State HDHP)
Does not cover GLP-1s for weight lossSince January 1, 2026, Michigan's State Health Plan PPO and State HDHP no longer cover GLP-1 drugs such as Wegovy, Zepbound and Saxenda for weight management or sleep apnea. They stay covered for diabetes and cardiovascular diagnoses.
The Civil Service Commission's 2026 open enrollment guide says weight-management GLP-1s left the SHP PPO and State HDHP on January 1, 2026, and that earlier weight-management approvals ended December 31, 2025.
“Effective January 1, 2026, GLP-1 inhibitors (e.g., Saxenda, Wegovy, and Zepbound) will no longer be covered under the SHP PPO and State HDHP for weight management or sleep apnea but will continue to be covered for diabetes management and cardiovascular diagnoses. All existing prior authorization approvals for GLP-1 inhibitors with a weight management or sleep apnea diagnosis will end effective December 31, 2025.”
Source: Michigan Civil Service Commission. Read October 29, 2026.
The 2026 retiree bulletin says the same change applies to retirees, except where Medicare requires coverage.
“Beginning January 1, 2026, the SHP will no longer cover the category of drugs known as GLP-1 inhibitors for weight management except when required by Medicare.”
Source: Michigan Civil Service Commission. Read October 29, 2026.
Blue Cross Blue Shield of Michigan and Blue Care Network
Blue Cross Blue Shield of Michigan and Blue Care Network stopped covering GLP-1s for weight loss, including Wegovy and Zepbound, for fully insured large-group members from January 1, 2025 or the group's 2025 renewal. Self-funded employers set their own rules.
Blue Cross's September 2024 provider alert says weight-loss GLP-1s, including Wegovy and Zepbound, are no longer covered from January 1, 2025 or the group's 2025 renewal date.
“Beginning Jan. 1, 2025, or on the group’s 2025 health coverage renewal date, Blue Cross Blue Shield of Michigan and Blue Care Network will no longer cover prescriptions for glucagon-like peptide-agonist drugs used for weight loss, including Saxenda®, Wegovy® and Zepbound®.”
Source: Blue Cross Blue Shield of Michigan. Read October 29, 2026.
The change covers fully insured large groups with a prescription drug plan; the alert adds that some self-funded groups have also removed coverage.
“This change applies to Blue Cross and BCN commercial members of fully insured large groups with a prescription drug plan.”
Source: Blue Cross Blue Shield of Michigan. Read October 29, 2026.
Comparing self-pay programs in Michigan?
2-minute quiz: filter by budget and medication preference.
Telehealth Programs to Check for Michigan
We list 49 programs here. 21 are recorded as available in all 50 states. 7 more publish their own state list, summarized below for Michigan. The rest record a state count without naming the states, so confirm Michigan with the program at intake before you pay.
What Programs' Own Pages Say About Michigan
8 of the 8 programs whose own pages name the states they serve include Michigan: Willow, SnagRx, Strut Health, MangoRx, Wellorithm, MEDGm, TelosRx, Trimi. Pages read November 9, 2026. This is what each seller states about availability, not a licensing check.
| Program | Michigan |
|---|---|
| Willow | Serves MI |
| SnagRx | Serves MI |
| Strut Health | Ships to MI |
| MangoRx | Ships to MI |
| Wellorithm | Serves MI |
| MEDGm | Serves MI |
| TelosRx | Serves MI |
| Trimi | Serves MI |
Trimi's state table lists Michigan as served through the Arora Health network. Visit format there: Online intake reviewed by a licensed provider; no in-person visit required. The telehealth law it cites for Michigan is Mich. Comp. Laws § 333.16285 (with §§ 333.16283 and 333.16284). That citation is Trimi's, not our legal reading. Trimi state table, read November 9, 2026.
Programs on Our List, in Published Order
Compounded GLP-1 care with one-month and prepaid plans
Personalized GLP-1 consultations with tailored prescriptions and ongoing physician support
Affordable compounded semaglutide from $119/mo with free shipping and health coaching
Personalized GLP-1 weight loss with licensed providers and nationwide coverage
45 more programs on our list: 19 recorded as available in all 50 states, 7 with a state list shown in the table above, and 19 with a state count but no published list we have read. Compare all of them side by side.
Estimated GLP-1 Costs in Michigan
Telehealth (Compounded)
$79 to $399/moRecorded monthly-plan prices for compounded semaglutide and tirzepatide. Availability varies by program, so confirm your state at intake.
Wegovy
Brand prices with and without insurance.
Zepbound
List, LillyDirect and savings card prices.
No insurance
Self-pay GLP-1 options without coverage.
The compounded range is our recorded monthly-plan prices, the same in every state. Brand and insurance costs depend on the plan, so we link the pages that carry their sources. Compounded medications are not FDA-approved.
Medicare Part D GLP-1 Claims in Michigan, 2024
Michigan prescribers wrote 768,388 Medicare Part D GLP-1 claims in 2024, number 8 of 51, with $1.00 billion in gross drug cost before rebates. Ozempic led with 296,257 claims for 59,414 enrollees. Wegovy had 6,653 claims. Part D did not pay for weight loss alone in 2024, so these fills are for diabetes and other approved uses.
| Product | MI Part D claims | Enrollees |
|---|---|---|
| Ozempic | 296,257 | 59,414 |
| Mounjaro | 206,141 | 37,369 |
| Trulicity | 205,468 | 39,944 |
| Rybelsus | 35,186 | 9,226 |
| Victoza | 9,492 | Not given |
| Bydureon Bcise | 6,801 | 1,470 |
| Wegovy | 6,653 | 1,533 |
| Liraglutide | 1,825 | 756 |
| Byetta | 565 | 156 |
Source: CMS Medicare Part D Prescribers by Geography and Drug, 2024 (updated May 21, 2026), state rows, read November 9, 2026. The state is the prescriber's. Claims include refills, and enrollees are not added across products because one person can fill two.
Medicare GLP-1 Bridge Program in Michigan
The Bridge is national, so the rules are the same in Michigan as everywhere: eligible Part D enrollees pay $50/month for Foundayo, Wegovy or Zepbound KwikPen, subject to BMI rules and exclusions. Medicare fact sheet.
$50/mo
July 1, 2026
Dec 31, 2027
How Michigan Compares to Other Midwest States
Medicaid coverage of GLP-1s for obesity is optional for states, so the answer differs by state. Here is how Michigan and its neighbors in the Midwest are recorded:
| State | Medicaid and GLP-1s for obesity | Medicaid GLP-1 Rx, 2025 |
|---|---|---|
| Michigan (this page) | Covered, January 2026 (KFF) | 607,982 |
| Illinois | Not covered | 288,470 |
| Indiana | Not covered | 190,013 |
| Iowa | Not covered | 88,518 |
| Kansas | Covered, January 2026 (KFF) | 50,850 |
| Minnesota | Covered, January 2026 (KFF) | 230,594 |
| Missouri | Covered, January 2026 (KFF) | 285,105 |
Our recorded telehealth prices are not state-specific: $79 to $399/month on monthly plans. Medicaid and marketplace coverage is what varies.
KFF counted 13 state Medicaid programs covering GLP-1s for obesity under fee-for-service as of January 2026. Managed care plans may differ. Later counts may be lower: The RX Index, an independent tracker, listed 11 in a July 10, 2026 snapshot and says that is not a current national count. Sources read November 6, 2026. Policies change, so confirm with your state Medicaid agency or plan.
If Your Insurance Denies GLP-1 Coverage in Michigan
Commercial plans offer an internal appeal, then external review; Michigan Medicaid enrollees can ask for a fair hearing. The denial letter names the deadlines.
How to Check Your Specific Plan in Michigan
- Michigan Medicaid: Medicaid: covered as of January 2026 (KFF). Ask your Medicaid plan for its drug list and prior authorization rules, or find the state agency on Medicaid.gov's state contacts.
- State employees: Michigan State Health Plan (SHP PPO and State HDHP), does not cover glp-1s for weight loss per the documents cited above. Confirm with the plan before you fill a prescription.
- Insurers on record for Michigan: Blue Cross Blue Shield of Michigan and Blue Care Network. Each still depends on whether your employer bought the weight-loss benefit.
- Any other plan: call the number on your card and ask whether Wegovy or Zepbound is covered for weight loss, which tier it sits on, and what prior authorization needs. Get the answer in writing.
Find the Right GLP-1 Provider in Michigan
Answer a few questions and we'll match you with the best GLP-1 program for your budget, insurance, and goals in Michigan.
Frequently Asked Questions — Michigan
Does Michigan Medicaid cover GLP-1 medications for weight loss?
How many GLP-1 prescriptions did Michigan Medicaid pay for in 2025?
How many Medicare Part D GLP-1 claims were there in Michigan in 2024?
Does the Michigan state employee health plan cover GLP-1s for weight loss?
What is the cheapest way to get GLP-1 medication in Michigan?
Which online GLP-1 programs serve Michigan?
Does Medicare cover GLP-1s in Michigan?
Ready to start?
Compare the recorded costs, sources and evidence gaps for 52 listed providers. Confirm current terms with the provider before enrolling.